Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...
DexCom, Inc. (DXCM), headquartered in California, is a leading player in the medical devices sector. Valued at a market cap ...
The BNY Mellon Small/Mid Cap Growth Fund (Class A at NAV) returned 3.05% during the third quarter of 2024. Read more here.
Shares of DexCom Inc. DXCM inched 0.89% higher to $78.41 Monday, on what proved to be an all-around grim trading session for ...
Major media outlets are giving wall-to-wall coverage to UnitedHealthcare CEO Brian Thompson’s murder while taking millions in ...
In the assessment of 12-month price targets, analysts unveil insights for DexCom, presenting an average target of $98.44, a ...
BNY Mellon Research Growth Fund (Class A at NAV) underperformed its benchmark, the Russell 1000® Growth Index, during the ...
Canaccord analyst William Plovanic raised the firm’s price target on DexCom (DXCM) to $99 from $89 and keeps a Buy rating on the shares.
DexCom Inc (DXCM) stock saw a decline, ending the day at $77.72 which represents a decrease of $-1.20 or -1.52% from the prior close of $78.92. The stock opened at $79.21 and touched a low of $77.33 ...
OK, I've been a little late coming up with my holiday gift guide, as we've already passed both Black Friday and Cyber Monday.
Shares of DexCom Inc. DXCM slipped 1.52% to $77.72 Friday, on what proved to be an all-around mixed trading session for the ...
DexCom Inc (DXCM) stock saw a decline, ending the day at $78.92 which represents a decrease of $-2.09 or -2.58% from the prior close of $81.01. The stock opened at $80.91 and touched a low of $78.06 ...